Skip to main content
SpringerLink
Log in

Preoperative Chemotherapy for Breast Cancer: Do We Need to Redefine Our End Points?

  • Editorials
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Danforth DN Jr., Cowan K, Altemus R, et al. Preoperative FLAC/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial. Ann Surg Oncol 2003; 10: 635–44.

    Article  PubMed  Google Scholar 

  2. Fisher B, Bryant J, Wolmark D, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998; 16: 2672–85.

    PubMed  CAS  Google Scholar 

  3. Dowsett M. Preoperative models to evaluate endocrine strategies for breast cancer. Clin Cancer Res 2003; 9: 502s–10s.

    PubMed  CAS  Google Scholar 

  4. Stearns V, Singh B, Tsangaris T, et al. A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. Clin Cancer Res 2003; 9: 124–33.

    PubMed  CAS  Google Scholar 

  5. Esserman L, Kaplan E, Partridge S, et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 2001; 8: 549–59.

    Article  PubMed  CAS  Google Scholar 

  6. Schelling M, Avril N, Nahrig J, et al. Positron emission tomography using [(18)F] fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 2000; 18: 1689–95.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Wisconsi, H4/744 CSC, Madison, WI, 53792

    Tara M. Breslin MD

Authors
  1. Tara M. Breslin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tara M. Breslin MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Breslin, T.M. Preoperative Chemotherapy for Breast Cancer: Do We Need to Redefine Our End Points?. Ann Surg Oncol 10, 716–717 (2003). https://doi.org/10.1245/ASO.2003.05.933

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.05.933

Search

Navigation